Rep. Walden: Bipartisan E&C Leaders Request FDA Briefing on Threat to U.S. Heparin Supply
July 30, 2019
July 30, 2019
WASHINGTON, July 30 -- Rep. Greg Walden, R-Oregon, ranking Republican member of the House Energy and Commerce Committee, issued the following news release:
Energy and Commerce Committee leaders sent a letter to Food and Drug Administration (FDA) Acting Commissioner Dr. Norman E. "Ned" Sharpless requesting briefings on the potential threat to the U.S. supply of heparin, the only anticoagulant drug used for open-heart surgeries and kidney dialysis.
The bipartisa . . .
Energy and Commerce Committee leaders sent a letter to Food and Drug Administration (FDA) Acting Commissioner Dr. Norman E. "Ned" Sharpless requesting briefings on the potential threat to the U.S. supply of heparin, the only anticoagulant drug used for open-heart surgeries and kidney dialysis.
The bipartisa . . .